//
SPECT and PET in ischemic heart failure
Respiratory Syncytial Virus and Associations With Cardiovascular Disease in Adults
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone
Risk of Mortality Following Catheter Ablation of Atrial Fibrillation
A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart Failure
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review